Literature DB >> 26920379

Benchmarks of meaningful impairment on the MSFC and BICAMS.

Ralph Hb Benedict1, Allison S Drake2, Lauren N Irwin2, Seth E Frndak2, Katrina A Kunker2, Anjum L Khan2, Victoria M Kordovski2, Robert W Motl3, Bianca Weinstock-Guttman2.   

Abstract

BACKGROUND: Cognitive and motor abilities in multiple sclerosis (MS) are typically quantified using reliable, consensus standard tests validated in the MS population. While these performance measures are associated with vocational disability in parametric analyses, translation of raw scores into anchors reflecting clinically relevant, functional impairment requires further research.
OBJECTIVE: To examine performance-based motor and cognitive outcomes among definitive anchors that designate varying degrees of functional impairment, thereby establishing benchmarks for score interpretation.
METHODS: We evaluated MS patients and healthy controls, all undergoing a brief test battery. Outcomes were derived from the MS Functional Composite (MSFC) and the Brief International Cognitive Assessment for MS (BICAMS). Functional impairment anchors were (1) disability benefits, (2) employed with negative work events, and (3) employed without problems.
RESULTS: All measures yielded statistically significant differences across all levels of work status, after accounting for the effects of age and education. Benchmark values distinguished the functional impairment groups. When evaluated in combination, the Timed 25-Foot Walk and the Symbol Digit Modalities Test were the most robust predictors of functional decline.
CONCLUSION: We have established benchmark scores for popular motor and cognitive tests that are associated with specific degrees of impairment in work status.
© The Author(s), 2016.

Entities:  

Keywords:  Multiple sclerosis; cognitive impairment; neuroperformance outcomes; work disability

Mesh:

Year:  2016        PMID: 26920379     DOI: 10.1177/1352458516633517

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

1.  Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.

Authors:  Myla D Goldman; Melanie D Ward; Robert W Motl; David E Jones; John H Pula; Diego Cadavid
Journal:  Mult Scler       Date:  2016-12-07       Impact factor: 6.312

2.  The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.

Authors:  M Filser; H Schreiber; J Pöttgen; S Ullrich; M Lang; I K Penner
Journal:  J Neurol       Date:  2018-08-31       Impact factor: 4.849

3.  Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis.

Authors:  Dawn W Langdon; Davorka Tomic; Iris-Katharina Penner; Pasquale Calabrese; Gary Cutter; Dieter A Häring; Frank Dahlke; Ludwig Kappos
Journal:  Eur J Neurol       Date:  2021-10-12       Impact factor: 6.288

4.  A Randomised Controlled Trial of Efficacy of Cognitive Rehabilitation in Multiple Sclerosis: A Cognitive, Behavioural, and MRI Study.

Authors:  J Campbell; D Langdon; M Cercignani; W Rashid
Journal:  Neural Plast       Date:  2016-12-27       Impact factor: 3.599

5.  Coping strategies in relation to negative work events and accommodations in employed multiple sclerosis patients.

Authors:  K van der Hiele; Dam van Gorp; Rhb Benedict; P J Jongen; Epj Arnoldus; Eac Beenakker; H M Bos; Jjj van Eijk; J Fermont; Stfm Frequin; B M van Geel; Gjd Hengstman; E Hoitsma; Rmm Hupperts; J P Mostert; Phm Pop; Wim Verhagen; D Zemel; S E Frndak; Map Heerings; Ham Middelkoop; L H Visser
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-11-24

6.  Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.

Authors:  Robert W Motl; Jeffrey A Cohen; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn D Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

7.  Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.

Authors:  Ralph Hb Benedict; John DeLuca; Glenn Phillips; Nicholas LaRocca; Lynn D Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

8.  Cognitive Functioning in Patients with Pediatric-Onset Multiple Sclerosis, an Updated Review and Future Focus.

Authors:  Joy B Parrish; Emily Fields
Journal:  Children (Basel)       Date:  2019-02-04

9.  Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.

Authors:  Curtis M Wojcik; Meghan Beier; Kathleen Costello; John DeLuca; Anthony Feinstein; Yael Goverover; Mark Gudesblatt; Michael Jaworski; Rosalind Kalb; Lori Kostich; Nicholas G LaRocca; Jonathan D Rodgers; Ralph Hb Benedict
Journal:  Mult Scler       Date:  2019-10-22       Impact factor: 6.312

Review 10.  Cognition in multiple sclerosis: State of the field and priorities for the future.

Authors:  James F Sumowski; Ralph Benedict; Christian Enzinger; Massimo Filippi; Jeroen J Geurts; Paivi Hamalainen; Hanneke Hulst; Matilde Inglese; Victoria M Leavitt; Maria A Rocca; Eija M Rosti-Otajarvi; Stephen Rao
Journal:  Neurology       Date:  2018-01-17       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.